Could knowing where your ancestors came from be the key to better cancer treatments? Maybe, but where would that key fit? How can we trace cancer's ancestral roots to modern-day solutions? For Cold Spring Harbor Laboratory (CSHL) Research Professor Alexander Krasnitz, the answers may lie dee
The Central government on Thursday clarified that it has not received any request from National Mission for Clean Ganga to conduct research on the use of Ganga river water as a cure for the COVID-19 virus.
Probiotic bacteria usually found in fermented foods, such as yoghurt, sourdough bread, and miso soup, might help dispel the embarrassment of persistent bad breath (halitosis), finds a pooled data analysis of the available evidence, published in the open access journal BMJ Open.
Neuroblastoma is a tumour of the sympathetic nervous system that occurs mainly in young children. Every year, 25 children in the Netherlands receive this diagnosis. Surgery to remove the tumour tissue forms an important part of the treatment plan. Since November 2014, care for children in th
Researchers at UConn Health, Yale, and Johns Hopkins have identified that some cancer cells can "cheat" by escaping constraints imposed by lack of oxygen, allowing the cancer cells to continue to grow.
Alzheimer's disease (AD) is the fifth leading cause of death in adults over 65 years old. While many potential treatments for neurodegenerative disease focus on developing drugs to target key culprits, a relatively new approach aims to treat the brain.
A new research study published in Family Practice, published by Oxford University Press, finds that when doctors tell patients living with obesity to lose weight the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.
After two years of chemotherapy treatment, nine out of ten children are cured. But some children have a more aggressive form of the disease. For example, children with a so-called Ikaros change in the DNA of their leukaemia cells have a greater risk of their disease coming back after treatme
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
A fundamental challenge in drug development is the balance between optimizing a drug's lock-and-key fit with its target and the drug's ability to make its way across the cellular membrane and access that target.